LFST LifeStance Health Group Inc

Price (delayed)

$7.645

Market cap

$2.96B

P/E Ratio

109.21

Dividend/share

N/A

EPS

$0.07

Enterprise value

$3.23B

?
Relative Growth: Rel. Growth: 63
Relative Strength: Rel. Strength: 68
Relative Valuation: Rel. Valuation: 49
Relative Profitability: Rel. Profitability: 53
Highlights
LFST's EPS has surged by 170% year-on-year and by 133% since the previous quarter
LFST's net income has soared by 165% YoY and by 140% from the previous quarter
The quick ratio has contracted by 2.9% from the previous quarter
LifeStance Health Group's equity has decreased by 2.9% from the previous quarter

Key stats

What are the main financial stats of LFST

LFST stock price

How has the LifeStance Health Group stock price performed over time
Intraday
1.93%
1 week
-2.11%
1 month
5.16%
1 year
28.49%
YTD
8.59%
QTD
20.02%

Financial performance

How have LifeStance Health Group's revenue and profit performed over time
Revenue
$1.49B
Gross profit
$487.24M
Operating income
$44.83M
Net income
$23.2M
Gross margin
32.6%
Net margin
1.6%
LFST's net income has soared by 165% YoY and by 140% from the previous quarter
The net margin has soared by 157% YoY and by 129% from the previous quarter
The operating income has surged by 86% since the previous quarter
The operating margin has surged by 76% since the previous quarter

Price vs fundamentals

How does LFST's price correlate with its fundamentals

Growth

What is LifeStance Health Group's growth rate over time

Valuation

What is LifeStance Health Group stock price valuation
P/E
109.21
P/B
2.02
P/S
1.98
EV/EBIT
73.42
EV/EBITDA
22.95
EV/Sales
2.16
LFST's EPS has surged by 170% year-on-year and by 133% since the previous quarter
LFST's price to book (P/B) is 24% higher than its last 4 quarters average of 1.6 but 6% lower than its 5-year quarterly average of 2.1
LifeStance Health Group's equity has decreased by 2.9% from the previous quarter
The price to sales (P/S) is 39% less than the 5-year quarterly average of 3.2 but 14% more than the last 4 quarters average of 1.7
The revenue has grown by 16% YoY and by 5% from the previous quarter

Efficiency

How efficient is LifeStance Health Group business performance
LifeStance Health Group's return on assets has surged by 175% QoQ and by 165% YoY
LifeStance Health Group's return on equity has surged by 164% YoY and by 129% QoQ
LFST's return on invested capital has surged by 85% since the previous quarter
LFST's return on sales has surged by 71% since the previous quarter

Dividends

What is LFST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LFST.

Financial health

How did LifeStance Health Group financials performed over time
LFST's current ratio is down by 10% QoQ
LFST's total assets is down by 2.6% since the previous quarter
The debt is 69% less than the equity
The debt to equity has grown by 3.3% from the previous quarter but it has contracted by 3.1% YoY
LifeStance Health Group's equity has decreased by 2.9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.